FDA
-
-
-
-
-
-
-
Tarsus and John Cena Partner to Raise Awareness of Demodex blepharitis, a Common Eyelid Disease Affecting Approximately 25 Million Americans
-
-
-
-
-
-
-
TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
-
-
-
-
-
-
-
Tarsus to Participate in Upcoming Investor Conference
-
-
-
-
-
-
-
Tarsus to Participate in Upcoming Investor Conferences
-
-
-
-
-
-
-
Tarsus to Present Several Scientific Abstracts Highlighting the Global Prevalence of Demodex Blepharitis and the Clinical Impact of XDEMVY at the American Society of Cataract and Refractive Surgery (A
-
-
-
-
-
-
-
Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025
-
-
-
-
-
-
-
Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
-
325,446 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

